Blog


Monday, April 13th 2026

Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer, 2010-2020

Ajjawi I, Loeb S, Cooperberg MR, Catalona WJ, Gross CP, Ma X, Leapman MS.  “Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer, 2010-2020” JAMA. 2024 Nov 20:e2420580. PMID: 39565605 Link: https://pubmed.ncbi.nlm.nih.gov/39565605/


Comment
Monday, April 13th 2026

Feasibility of Pay for Performance and Transparency Interventions on the Selection and Quality of Observational Management for Patients with Low-Risk Prostate Cancer in the Community Practice

Gaylis FD, Leapman MS, Ellis SD, Hu S, Cooperberg MR, Loeb S, Chen RC, Cohen ES, Dato PE, Aynehchi S, David R, Topp R, Santomauro B, Ginsburg K, Catalona WJ.  “Feasibility of Pay for Performance and Transparency Interventions on the Selection and Quality of Observational Management for Patients with Low-Risk Prostate Cancer in the Community… Read More


Comment
Monday, April 13th 2026

Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis

Catto JWF, Murphy D, Loeb S. “Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis” JAMA. 2025 Aug 19;334(7):641. PMID: 40658431 Link: https://pubmed.ncbi.nlm.nih.gov/40658431/


Comment
Monday, April 13th 2026

Navigating the Scoring Systems and Interpretation Frameworks of Prostate-specific Membrane Antigen PET

Woo S, Masci B, Rowe SP, Caruso D, Laghi A, Burger IA, Fanti S, Herrmann K, Eiber M, Loeb S, Vargas HA. “Navigating the Scoring Systems and Interpretation Frameworks of Prostate-specific Membrane Antigen PET” Radiology. 2025 Dec;317(3):e250701. PMID: 41363980 Link: https://pubmed.ncbi.nlm.nih.gov/41363980/


Comment
Monday, April 13th 2026

PSMA PET/CT Reporting: Real-Life Inconsistencies, Heterogeneity, and Underutilization of Scoring Systems and Interpretation Frameworks

Vargas HA, Fanti S, Herrmann K, Eiber M, Rowe SP, Rivera A, Pitsoulakis E, Becker A, Woo S, Loeb S. “PSMA PET/CT Reporting: Real-Life Inconsistencies, Heterogeneity, and Underutilization of Scoring Systems and Interpretation Frameworks” Radiology. 2025 Oct;317(1):e250702. PMID: 41085399 Link: https://pubmed.ncbi.nlm.nih.gov/41085399/


Comment
Monday, April 13th 2026

Geographic variability in contemporary utilization of PET imaging for prostate cancer: a medicare claims cohort study

Korn SM, Qian Z, Zurl H, Hansen N, Pohl KK, Stelzl D, Dagnino F, Lipsitz S, Zhang J, Kibel AS, Moore CM, Kilbridge KL, Shariat SF, Loeb S, Vargas HA, Trinh QD, Cole AP. “Geographic variability in contemporary utilization of PET imaging for prostate cancer: a medicare claims cohort study” Cancer Imaging. 2025 Jul 4;25(1):86…. Read More


Comment
Monday, April 13th 2026

Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PIRADS 5 findings on prostate MRI

Sundaresan VM, Webb L, Rabil M, Golos A, Sutherland R, Bailey J, Rajwa P, Seibert TM, Loeb S, Cooperberg MR, Catalona WJ, Sprenkle PC, Kim IY, Leapman MS. “Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PIRADS 5 findings on prostate MRI” Urol Oncol. 2025 Mar;43(3):193.e19-193.e26. PMID: 39706698 Link:… Read More


Comment
Monday, April 13th 2026

Disparities in tissue-based biomarker testing among US Medicare beneficiaries with prostate cancer

Korn SM, Qian Z, Zurl H, Piccolini A, Pohl KK, Lipsitz S, Zhang J, Kibel AS, Moore CM, Rana HQ, Kilbridge KL, Shariat SF, Loeb S, Trinh QD, Cole AP. “Disparities in tissue-based biomarker testing among US Medicare beneficiaries with prostate cancer” JNCI Cancer Spectr. 2025 Jul 1;9(4):pkaf051. PMID: 4037823 Link: https://pubmed.ncbi.nlm.nih.gov/40378235/


Comment
Monday, April 13th 2026

Estimating the Carbon Emissions of a Single Prostate-specific Antigen Test: Results from a Cradle-to-grave Life Cycle Assessment

Zurl H, Korn SM, Pohl KK, Qian Z, Piccolini A, Iyer HS, Leapman MS, Ahyai S, Shariat SF, Trinh QD, Thiel CL, Loeb S, Cole AP. “Estimating the Carbon Emissions of a Single Prostate-specific Antigen Test: Results from a Cradle-to-grave Life Cycle Assessment” Eur Urol Focus. 2025 Aug 1:S2405-4569(25)00211-1. PMID: 40753028 Link: https://pubmed.ncbi.nlm.nih.gov/40753028/


Comment
Monday, April 13th 2026

Geographic Variability in Germline Genetic Testing for Prostate Cancer: A Nationwide Medicare Claims Study With Evidence of Low Uptake

Korn SM, Qian Z, Zurl H, Piccolini A, Pohl KK, Lipsitz SR, Zhang J, Kibel AS, Moore CM, Rana HQ, Kilbridge KL, Shariat SF, Giri VN, Loeb S, Trinh QD, Cole AP. “Geographic Variability in Germline Genetic Testing for Prostate Cancer: A Nationwide Medicare Claims Study With Evidence of Low Uptake” J Natl Compr Canc… Read More


Comment
Monday, April 13th 2026

Impact of variants of uncertain significance on decision making about genetic testing for Hispanic males

Saunders J, Giri VN, Vadaparampil S, Rivera A, Sanchez Nolasco T, Rangel Camacho M, Byrne N, Owens K, Santacatterina M, Loeb S. “Impact of variants of uncertain significance on decision making about genetic testing for Hispanic males” Genet Med Open. 2025 Dec 1;4:103480. PMID: 41540976 Link: https://pubmed.ncbi.nlm.nih.gov/41540976/


Comment
Monday, April 13th 2026

A Social Media Campaign and Web-Based Survey About Prostate Cancer Genetics: Mixed Methods Study

Leader AE, Loeb S, Selvan P, Hunter A, Hartman R, Keith SW, Giri VN. “A Social Media Campaign and Web-Based Survey About Prostate Cancer Genetics: Mixed Methods Study” JMIR Cancer. 2025 Oct 14;11:e69787. PMID: 41086012 Link: https://pubmed.ncbi.nlm.nih.gov/41086012/


Comment
Monday, April 13th 2026

Patient-Reported Outcomes From Males Regarding Germline Testing for Prostate Cancer: Results From the PROGRESS Registry

Loeb S, Keith SW, Gross L, Hartman RL, Beer TM, Brierley KL, Cheng HH, Couvillon A, Dicker AP, Friedman S, Gomella LG, Karsh L, Kelly WK, Lallas CD, Leader AE, Mann MJ, Mark JR, Mille P, Paller CJ, Rana HQ, Sokolova AO, Trabulsi EJ, Whang YE, Giri VN. “Patient-Reported Outcomes From Males Regarding Germline Testing… Read More


Comment
Monday, April 13th 2026

Knowledge and attitudes toward prostate cancer germline genetic testing among Hispanic males

Saunders J, Giri VN, Vadaparampil ST, Rivera A, Sanchez Nolasco T, Rangel Camacho M, Byrne N, Santacatterina M, Loeb S. “Knowledge and attitudes toward prostate cancer germline genetic testing among Hispanic males” Prostate Cancer Prostatic Dis. 2025 Aug 7. PMID: 40775448 Link: https://pubmed.ncbi.nlm.nih.gov/40775448/


Comment
Monday, April 13th 2026

Germline testing for prostate cancer: current state and opportunities for enhanced access

Loeb S, Vadaparampil ST, Giri VN. “Germline testing for prostate cancer: current state and opportunities for enhanced access” EBioMedicine. 2025 Jun;116:105705. PMID: 40398351 Link: https://pubmed.ncbi.nlm.nih.gov/40398351/


Comment
Monday, April 13th 2026

Quality of English- and Spanish-language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities

Abusamra SM, Cholán VO, Giri VN, Vadaparampil ST, Pérez-Rosas V, Rivera A, Nolasco TS, Camacho MR, Byrne N, Loeb S. “Quality of English- and Spanish-language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities” BJUI Compass. 2025 Mar 23;6(3):e70011. PMID: 40129444 Link: https://pubmed.ncbi.nlm.nih.gov/40129444/


Comment
Monday, April 13th 2026

Dietary Patterns in Prostate Cancer Prevention and Management: A Systematic Review of Prospective Cohort Studies and Randomized Clinical Trials

Lin PH, Burwell AD, Giovannucci EL, Loeb S, Chan JM, Tuttle B, Nunzio C, Bjartell A, Aronson W, Freedland SJ. “Dietary Patterns in Prostate Cancer Prevention and Management: A Systematic Review of Prospective Cohort Studies and Randomized Clinical Trials”  Eur Urol. 2025 Aug 19:S0302-2838(25)00433-6. PMID: 40835500     Link: https://pubmed.ncbi.nlm.nih.gov/40835500/


Comment
Monday, April 13th 2026

European Association of Urology Congress

London, UK. March 2026. Topic: ISSM/Movember Thematic Session- Partner Issues & Lifestyle Category: Prostate Cancer, Survivorship, Sexual Health, Nutrition


Comment
Monday, April 13th 2026

Toronto Prostate Cancer Genetics Retreat

Toronto, Canada. October 2025. Topic: Facilitators, Barriers and Disparities in Genetic Evaluation for Prostate Cancer Category: Prostate Cancer, Genetics, Health Equity


Comment
Monday, April 13th 2026

European Association of Urology Congress

Madrid, Spain. March 2025. Topic: Vigilancia activa para el cáncer de próstata; State-of-the-art lecture Methods for evaluating the carbon footprint within the healthcare system Category: Prostate Cancer, Active Surveillance, Sustainability


Comment
Monday, April 13th 2026

Illuminate Oncology Town Hall 2.0

Mumbai, India. February 2025. Topic: Diet in Prostate Cancer Category: Nutrition, Prostate Cancer


Comment
Monday, April 13th 2026

8th International Endourology/ Oncology at Hospital Alemán

Buenos Aires, Argentina. December 2024. Topic: Medios Sociales en Uro-oncología; Vigilancia activa para el cáncer de próstata; Testeo genético para el cáncer de próstata Category: Social Media, Prostate Cancer, Active Surveillance, Genetics


Comment
Monday, April 13th 2026

3rd Annual Aswan Urology Meeting

Aswan, Egypt. January 2026. Lecture Topic: Updates on Prostate Cancer Screening and Active Surveillance Category: Prostate Cancer, Screening, Active Surveillance


Comment
Monday, April 13th 2026

American Urological Association- Egyptian Urological Association Joint Symposia

Cairo, Egypt. November 2024. Lecture Topics: Prostate cancer epidemiology and genetics; Prostate cancer screening and detection; Active surveillance for prostate cancer Category: Prostate Cancer, Screening, Genetics, Active Surveillance


Comment
Monday, April 13th 2026

Egyptian Urological Association

Hurghada, Egypt. November 2024. Lecture Topic: Promise and Peril of Social Media in Urology Category: Social Media


Comment
Monday, April 13th 2026

Advanced Prostate Cancer Consensus Conference Diagnostics

Lugano, Switzerland. February 2025. Topic: Patient Centered Reports Category: Prostate Cancer, Health Communications


Comment
Monday, April 13th 2026

14th Focus on Urology

Lucerne, Switzerland. October 2024. Topic: Sustainability in Urology Category: Sustainability


Comment
Monday, April 13th 2026

UC San Diego Prostate Cancer Patient Summit

San Diego, CA. January 2026. Topic: Fueling Your Fight: Evidence-Based Nutrition for Prostate Cancer Health Category: Prostate Cancer, Survivorship, Nutrition


Comment
Monday, April 13th 2026

American Cancer Society Cancer Research Symposium

Sarasota, Florida. November 2025. Topic: Communication and Misinformation about Prostate Cancer Screening Category: Prostate Cancer, Social Media


Comment
Monday, April 13th 2026

Consortium on Disparities of Urological Cancer (ConDUC) Prostate Cancer Symposium

Atlanta, Georgia. November 2025. Topics: Disparities in Genetic Testing for Minoritized Groups; Everyday Choices, Lifelong Impact: Lifestyle Category: Prostate Cancer, Genetics; Nutrition, Lifestyle


Comment
Monday, April 13th 2026

Large Urology Group Practice Association (LUGPA) Annual Meeting

Chicago, Illinois. November 2025. Topic: Current State of Prostate Cancer Screening Category: Prostate Cancer, Screening


Comment
Monday, April 13th 2026

International Society for Sexual Medicine/ Movember Webinar

The Netherlands (Virtual). November 2025. Topic: Involving Partners and the Biopsychosocial Approach Category: Sexual Health, Survivorship


Comment
Monday, April 13th 2026

University of Pennsylvania Urology Grand Rounds

Pennsylvania USA (Virtual). October 2025. Topic: Lifestyle Medicine: For Urology Patients and Providers Category: Lifestyle, Nutrition


Comment
Monday, April 13th 2026

Virginia Community Healthcare Association Annual Meeting & Conference

Virginia USA (Virtual). September 2025. Topic: Strategies to Overcome Misinformation Category: Social Media


Comment
Monday, April 13th 2026

Medical College of Wisconsin Grand Rounds

Wisconsin USA (Virtual). July 2025. Topic: Plant-Based Diet and Prostate Cancer Category: Lifestyle, Nutrition, Prostate Cancer


Comment
Monday, April 13th 2026

Sociedad Chilena de Urología

Chile (Virtual). April 2025. Topic: Optimización del estilo de vida para Urólogos Category: Nutrition


Comment
Monday, April 13th 2026

Virginia Public Health Summit on Cancer

Virginia. June 2025. Topic: Strategies to Overcome Misinformation Category: Social Media


Comment
Monday, April 13th 2026

American Society for Men’s Health

Las Vegas, Nevada. April 2025. Topic: Lifestyle Medicine and its Utility in the Men’s Health Space Category: Lifestyle, Nutrition, Sexual Health


Comment
Monday, April 13th 2026

Southeastern Section of the American Urological Association

Nashville, Tennessee. March 2025. Topic: Promise and Peril of the Internet in Urology Category: Social media


Comment
Monday, April 13th 2026

OncLive Bridging Gaps in Prostate Cancer

New Jersey. March 2025. Topic: The Role of Diet and Exercise in Management of Prostate Cancer Category: Nutrition, Prostate Cancer, Survivorship


Comment